Literature DB >> 19029201

Cooperation of specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) and complement receptor type 3 (CR3) in the uptake of oligomannose-coated liposomes by macrophages.

Hideaki Takagi1, Maki Numazaki, Toshimitsu Kajiwara, Yu Abe, Mariko Ishii, Chiaki Kato, Naoya Kojima.   

Abstract

Resident peritoneal macrophages (PEMs) express SIGNR1 on the cell surface as a major mannose receptor. These cells also ingest oligomannose-coated liposomes (OMLs) in an oligomannose-dependent manner following intraperitoneal administration. Therefore, the current study was conducted to investigate the possible role of SIGNR1 in capture of OMLs. Transient expression of several SIGN-related lectins potentially expressed on PEMs in CHO cells revealed that only SIGNR1 contributed to capture of OMLs. When SIGNR1 was introduced into mouse macrophage-like RAW264.7 cells, SIGNR1-expressing RAW (RAW-SIGNR1) cells recognized OMLs under serum-free conditions. OML recognition by RAW-SIGNR1 cells as well as that by PEMs was partially inhibited by an anti-SIGNR1 antibody (ER-TR9) and by mannan, and completely inhibited by EDTA. Interestingly, OML recognition by RAW-SIGNR1 cells was accelerated in the presence of serum, partially inhibited by an anti-complement receptor 3 (CR3) antibody (M1/70), and almost completely inhibited by a combination of ER-TR9 and M1/70. Complete inhibition of OML ingestion by the combination of ER-TR9 and M1/70 was also observed under serum-free conditions, suggesting that SIGNR1 and CR3 cooperate in an additive way in capture of OMLs by macrophage-like RAW cells. Administration of ER-TR9 or M1/70 into the peritoneal cavity led to a significant decrease of OML uptake by PEMs. Therefore, SIGNR1 expressed on macrophages acts as a receptor for recognition of OMLs under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19029201     DOI: 10.1093/glycob/cwn128

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  10 in total

1.  Preferences for uptake of carbohydrate-coated liposomes by C-type lectin receptors as antigen-uptake receptors.

Authors:  Yoko Kawauchi; Yasuhiro Kuroda; Naoya Kojima
Journal:  Glycoconj J       Date:  2012-06-26       Impact factor: 2.916

2.  SIGNR1 ligation on murine peritoneal macrophages induces IL-12 production through NFkappaB activation.

Authors:  Chiaki Kato; Naoya Kojima
Journal:  Glycoconj J       Date:  2010-06-30       Impact factor: 2.916

3.  In vitro activation and maturation of human mononuclear phagocytes by stimulation with liposomes coated with a neoglycolipid containing α1-3, α1-6-mannotriose.

Authors:  Yuko Matsuoka; Yoko Kawauchi; Kiyotaka Kawauchi; Akari Takiyama; Shohei Kojima; Yasuhiro Kuroda; Naoya Kojima
Journal:  Glycoconj J       Date:  2019-04-23       Impact factor: 2.916

Review 4.  Recent advancements in cytotoxic T lymphocyte generation methods using carbohydrate-coated liposomes.

Authors:  Yuzuru Ikehara; Masahiro Yamanaka; Takashi Yamaguchi
Journal:  J Biomed Biotechnol       Date:  2010-06-17

5.  Immunization with oligomannose-coated liposome-entrapped dense granule protein 7 protects dams and offspring from Neospora caninum infection in mice.

Authors:  Yoshifumi Nishikawa; Houshuang Zhang; Yuzuru Ikehara; Naoya Kojima; Xuenan Xuan; Naoaki Yokoyama
Journal:  Clin Vaccine Immunol       Date:  2009-04-08

6.  Mucosal adjuvant activity of oligomannose-coated liposomes for nasal immunization.

Authors:  Mariko Ishii; Naoya Kojima
Journal:  Glycoconj J       Date:  2009-10-09       Impact factor: 2.916

7.  Targeted liposomal drug delivery to monocytes and macrophages.

Authors:  Ciara Kelly; Caroline Jefferies; Sally-Ann Cryan
Journal:  J Drug Deliv       Date:  2010-10-26

8.  Plasmodium berghei circumsporozoite protein encapsulated in oligomannose-coated liposomes confers protection against sporozoite infection in mice.

Authors:  Mohamad Alaa Terkawi; Yasuhiro Kuroda; Shinya Fukumoto; Sachi Tanaka; Naoya Kojima; Yoshifumi Nishikawa
Journal:  Malar J       Date:  2014-11-05       Impact factor: 2.979

9.  Pivotal advance: The promotion of soluble DC-SIGN release by inflammatory signals and its enhancement of cytomegalovirus-mediated cis-infection of myeloid dendritic cells.

Authors:  N Plazolles; J-M Humbert; L Vachot; B Verrier; C Hocke; F Halary
Journal:  J Leukoc Biol       Date:  2010-10-12       Impact factor: 4.962

Review 10.  Oligomannose-coated liposome as a novel adjuvant for the induction of cellular immune responses to control disease status.

Authors:  Naoya Kojima; Mariko Ishii; Yoko Kawauchi; Hideaki Takagi
Journal:  Biomed Res Int       Date:  2013-10-10       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.